Marco Mula1, Andres M Kanner1, Nathalie Jetté1, Josemir W Sander1. 1. Institute of Medical and Biomedical Education (MM), St George's University of London and the Atkinson Morley Regional Neuroscience Centre, St George's University Hospitals NHS Foundation Trust, London, United Kingdom; Department of Neurology (AMK), Comprehensive Epilepsy Center and Epilepsy Division, University of Miami, Miller School of Medicine, FL; Division of Epilepsy and Division of Health Outcomes and Knowledge Translation Research (NJ), Department of Neurology, Icahn School of Medicine at Mount Sinai, New York; NIHR UCL Hospitals Biomedical Research Centre (JWS), UCL Queen Square Institute of Neurology, London, and Chalfont Centre for Epilepsy, Chalfont St Peter, United Kingdom; and Stichting Epilepsie Instellingen Nederland-SEIN (JWS), Heemstede, the Netherlands.
Abstract
PURPOSE OF REVIEW: To review the latest evidence concerning the epidemiology, clinical implications, and management of psychiatric disorders in epilepsy. RECENT FINDINGS: People with epilepsy have a 2-5 times increased risk of developing any psychiatric disorder, and 1 in 3 patients with epilepsy have a lifetime psychiatric diagnosis. Psychiatric comorbidities represent a poor prognostic marker as they have been associated with a poor response to treatment (drugs and surgery), increased morbidity, and mortality. Validated screening instruments are available for mood and anxiety disorders in adults as well as attention-deficit hyperactivity disorder in children with epilepsy. SUMMARY: All patients with epilepsy should be routinely screened for psychiatric disorder at the onset and at least once a year. Patients with epilepsy and their relatives should be informed of the risk of mental health problems and the implications.
PURPOSE OF REVIEW: To review the latest evidence concerning the epidemiology, clinical implications, and management of psychiatric disorders in epilepsy. RECENT FINDINGS: People with epilepsy have a 2-5 times increased risk of developing any psychiatric disorder, and 1 in 3 patients with epilepsy have a lifetime psychiatric diagnosis. Psychiatric comorbidities represent a poor prognostic marker as they have been associated with a poor response to treatment (drugs and surgery), increased morbidity, and mortality. Validated screening instruments are available for mood and anxiety disorders in adults as well as attention-deficit hyperactivity disorder in children with epilepsy. SUMMARY: All patients with epilepsy should be routinely screened for psychiatric disorder at the onset and at least once a year. Patients with epilepsy and their relatives should be informed of the risk of mental health problems and the implications.
Authors: Gail S Bell; Jane de Tisi; Juan Carlos Gonzalez-Fraile; Janet L Peacock; Andrew W McEvoy; William F J Harkness; Jacqueline Foong; Rebecca A Pope; Beate Diehl; Josemir W Sander; John S Duncan Journal: J Neurol Neurosurg Psychiatry Date: 2017-09-04 Impact factor: 10.154
Authors: Hamada H Altalib; Anne T Berg; Xiangyu Cong; Barbara G Vickrey; Michael R Sperling; Shlomo Shinnar; John T Langfitt; Thaddeus S Walczak; Carl W Bazil; Nitin Sukumar; Orrin Devinsky Journal: Epilepsy Behav Date: 2018-04-07 Impact factor: 2.937
Authors: Philippe De Deurwaerdère; Maurizio Casarrubea; Daniel Cassar; Manuela Radic; Emilie Puginier; Abdeslam Chagraoui; Giuseppe Crescimanno; Vincenzo Crunelli; Giuseppe Di Giovanni Journal: Front Cell Neurosci Date: 2022-05-23 Impact factor: 6.147